- Report
- July 2024
- 150 Pages
Global
From €3434EUR$3,750USD£2,924GBP
- Drug Pipelines
- July 2024
- 100 Pages
Global
From €3434EUR$3,750USD£2,924GBP
- Report
- July 2024
- 100 Pages
Global
From €3434EUR$3,750USD£2,924GBP
- Report
- July 2024
- 100 Pages
Global
From €3434EUR$3,750USD£2,924GBP
- Report
- July 2024
- 100 Pages
Global
From €3434EUR$3,750USD£2,924GBP
- Report
- July 2024
- 180 Pages
Global
From €4121EUR$4,500USD£3,509GBP
- Report
- April 2025
- 130 Pages
Global
From €4350EUR$4,750USD£3,704GBP
- Report
- January 2025
Global
From €6869EUR$7,500USD£5,848GBP
- Report
- December 2024
Global
From €31596EUR$34,500USD£26,900GBP
- Report
- September 2024
- 162 Pages
Asia Pacific
From €2290EUR$2,500USD£1,949GBP
- Report
- September 2024
- 162 Pages
Europe
From €2290EUR$2,500USD£1,949GBP
- Report
- September 2024
- 158 Pages
North America
From €2290EUR$2,500USD£1,949GBP
- Report
- August 2024
- 180 Pages
Asia Pacific
From €3543EUR$3,869USD£3,017GBP
- Report
- December 2024
United States
From €3205EUR$3,500USD£2,729GBP
- Report
- August 2024
Europe, United Kingdom, ... Europe, United Kingdom, Spain, Italy, Germany, France
From €6869EUR$7,500USD£5,848GBP
- Report
- August 2024
Japan, United States, ... Japan, United States, Europe
From €8700EUR$9,500USD£7,407GBP
- Report
- July 2020
- 269 Pages
Global
From €3203EUR$3,497USD£2,727GBP
- Report
- September 2020
- 235 Pages
Global
From €4487EUR$4,899USD£3,820GBP
- Report
- March 2020
- 137 Pages
Global
From €4487EUR$4,899USD£3,820GBP
- Report
- December 2022
- 325 Pages
Global
From €4802EUR$5,427USD£3,950GBP

The Coronavirus Diagnostics market is a rapidly growing sector of the healthcare industry. It is focused on the development and production of tests and other diagnostic tools to detect the presence of the virus. These tests are used to identify individuals who have been infected with the virus, as well as those who may have been exposed to it. Diagnostics are also used to monitor the spread of the virus and to track its mutations.
The market is composed of a variety of companies, ranging from large multinationals to small startups. These companies are developing a range of tests, from rapid antigen tests to more complex molecular tests. They are also developing technologies to improve the accuracy and speed of testing, as well as to reduce the cost of testing.
Some of the major players in the Coronavirus Diagnostics market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, Roche Diagnostics, and Thermo Fisher Scientific. Other companies in the market include BioMedomics, BioFire Diagnostics, Luminex, and Quidel. Show Less Read more